SGEN

Seagen Inc.

Application Filed: 2023-01-24

Trademark Application Details

Mark For: SGEN™ trademark registration is intended to cover the categories of pharmaceutical research and development services; biotechnology research, namely, pharmaceutical product research and development of drug therapies and diagnostic tests for the treatment of cancer and immunological diseases.

Status

2023-01-27 UTC

LIVE APPLICATION Awaiting Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	97766623
Mark Literal Elements	SGEN
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	Service Mark
Current Location	NEW APPLICATION PROCESSING 2023-01-27
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	100: Miscellaneous 101: Advertising and Business
Primary International Class	042 - Primary Class (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Harold Milstein
Attorney Docket Number	65MK-289600

Timeline

2023-01-24	Application Filed
2023-01-27	Location: NEW APPLICATION PROCESSING
2023-01-27	Status: Live/Pending
2023-01-27	Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
2023-01-27	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	Seagen Inc.
Address	21823 30TH DRIVE S.E. BOTHELL, WASHINGTON UNITED STATES 98021
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Application		2023-01-24
Drawing		2023-01-24

Attorney of Record

HAROLD MILSTEIN
SHEPPARD MULLIN RICHTER & HAMPTON LLP
1540 EL CAMINO REAL SUITE 120
MENLO PARK, CA 94025

Good, Services, and Codes

International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0421	Pharmaceutical research and development services; biotechnology research, namely, pharmaceutical product research and development of drug therapies and diagnostic tests for the treatment of cancer and immunological diseases

Trademark Filing History

Description	Date	Proceeding Number
NEW APPLICATION ENTERED	2023-01-27

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
SGEN 98633325 not registered Live/Pending	Wang, Su Mei 2024-07-04
SGEN 97766623 not registered Live/Pending	Seagen Inc. 2023-01-24
SGEN 97017710 not registered Live/Pending	Guangzhou Sinogen Pharmaceutical Co., Ltd. 2021-09-08
SGEN 73761038 1543373 Dead/Cancelled	CONVERGENT, INC. 1988-10-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.